Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05399368 · ClinicalTrials.gov registry record · Phase 2
An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis
A Phase 2 study, sponsored by RAPT Therapeutics.
- Terminated
- Registry status
- Phase 2
- Development phase
- 229
- Enrollment target
NCT05399368 is a Phase 2 study that was terminated before completion, run by RAPT Therapeutics. The registered enrollment target is 229 participants.
The verdict
NCT05399368, a Phase 2 study, was terminated before completion, sponsored by RAPT Therapeutics.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 229 participants
- Enrollment target
Study Summary
Phase 2 study of RPT193 in adults with atopic dermatitis
Interventions
- OTHER Placebo
- DRUG RPT193
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 229 participants |
| Start Date | 2022-06-07 |
| Est. Completion | 2024-05-24 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05399368
The ClinicalTrials.gov registry entry for NCT05399368 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 229 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAPT Therapeutics, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05399368 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05399368 about?
NCT05399368 is a clinical study titled "An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis". Phase 2 study of RPT193 in adults with atopic dermatitis
What is the current status of trial NCT05399368?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 229 participants. The study started on 2022-06-07. Estimated completion is 2024-05-24.
What interventions are being tested in trial NCT05399368?
The interventions under investigation include: Placebo (OTHER), RPT193 (DRUG).
Who is sponsoring clinical trial NCT05399368?
This trial is sponsored by RAPT Therapeutics, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.